Western Drug Companies Accused Of Medical Trials On Unsuspecting East Germans
redOrbit Staff & Wire Reports - Your Universe Online Western drug companies tested pharmaceuticals on more than 50,000 people in the former communist East Germany, several of whom died, the German weekly Der Spiegel reported this week,...
Latest Clinical trial Stories
WESTFIELD, N.J., May 23, 2013 /PRNewswire-USNewswire/ -- Stephen L. DeFelice, M.D., Founder and Chairman of FIM, The Foundation for Innovation in Medicine, released a new video criticizing mainstream health care cost projections of Medicare, Medicaid and Obamacare, among others, because they omit the discovery of cures. He cites a boom in technology, including gene modification and new organ growth as inevitable in curing many of our major costly diseases. (To view the video and...
Award presented for the poster Contact-Free Under the Mattress Monitoring for Early Recognition of End-of-Life in Med/Surg Units WALTHAM, Massachusetts, May 23, 2013 /PRNewswire/ -- EarlySense, the market leader in Proactive Patient Care Solutions(TM), announced today that the prize for 'Best Novel Idea' at the 8th Annual Rapid Response Systems and Medical Emergency Teams International Conference, hosted this year in the UK by the Royal College of Physicians, was awarded to a...
BUSAN, South Korea, May 23, 2013 /PRNewswire/ -- Pusan National University Yangsan Hospital, in collaboration with SillaJen, Inc., a private biotherapeutics and contract research company focused on research and development of targeted biological products for cancer, announced today a publication reporting the induction of functional anti-cancer antibodies in patients treated with the oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex Inc.). This...
Prospective, Multi-Center, Double-Blinded Study Confirms Prior Results in evaluating Volcano's iFR® (Instant Wave-Free Ratio(TM)) Software Modality in a Large, Real-World Population SAN DIEGO and PARIS, May 23, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced preliminary results from the ADVISE...
BioScience Laboratories, Inc. Clinical Laboratory has again exceeded market standards for Phase 1 Dermatological Safety Studies for an IND submission. Phase I Dermatological Safety Studies represent a critical transition into the human model for every IND and ANDA submission. Bozeman, MT (PRWEB) May 22, 2013 BioScience Laboratories clinical laboratory has again exceeded market standards for Phase 1 Dermatological Safety Studies for an IND submission. Twenty-two years of experience has...
RALEIGH, N.C., May 22, 2013 /PRNewswire/ -- STEPh, Inc., a full service medical communications company, is pleased to announce the launch of their web site ( http://www.stephreports.com ) dedicated to investigational drug reports [STEPh Reports]. About STEPh Reports STEPh Reports are comprehensive critical reviews of drugs in development. Each STEPh Report assesses the competitive landscape by individual drug monograph, MOA, clinical trials data, projected launch year, company,...
DALLAS, May 22, 2013 /PRNewswire-iReach/ -- MarketReportsOnline.com announces addition of new market research report "China Pharmaceutical Guidebook Series (4) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines" to its online database. The traditional medicines in Orient, especially, the traditional Chinese medicines...
Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the progression of the disease. In this issue of the Journal of Clinical Investigation, Dr. Thomas Foltynie and colleagues at the National Hospital for Neurology and Neurosurgery in London investigated the use of a drug approved for diabetes care, Exenatide, in PD patients. PD...
Unexpected drug toxicities occurring years after prescription drug approval MCLEAN, Va., May 21, 2013 /PRNewswire/ -- In the last ten years, many people have developed unexpected toxicities from prescription drugs that had been on the market for several years. Researchers have been baffled. Dr. Dorothy L. Smith, a leading expert in the development of patient adherence programs, suggests unexpected toxicities could occur when patients in real-life have better patient adherence than...
PHILADELPHIA, May 21, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony(®) CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, announced today that the Company's clinical trial of its Symphony CGM System has received Institutional Review Board (IRB) approval. The IRB approval enables the commencement of a clinical evaluation of Symphony that will support the Company's CE Mark Technical...
